Premium
Coronavirus Disease 2019 and Liver Transplantation: Lessons from the First Year of the Pandemic
Author(s) -
Phipps Meaghan M.,
Verna Elizabeth C.
Publication year - 2021
Publication title -
liver transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.814
H-Index - 150
eISSN - 1527-6473
pISSN - 1527-6465
DOI - 10.1002/lt.26194
Subject(s) - medicine , liver transplantation , transplantation , pandemic , covid-19 , disease , liver disease , population , intensive care medicine , coronavirus , infectious disease (medical specialty) , virology , environmental health , outbreak
Over the last year, the novel coronavirus disease 2019 (COVID‐19) has continued to spread across the globe, causing significant morbidity and mortality among transplantation candidates and recipients. Patients with end‐stage liver disease awaiting liver transplantation and patients with a history of liver transplantation represent vulnerable populations, especially given the high rates of associated medical comorbidities in these groups and their immunosuppressed status. In addition, concerns surrounding COVID‐19 risk in this patient population have affected rates of transplantation and general transplantation practices. Here, we explore what we have learned about the impact of COVID‐19 on liver transplantation candidates and recipients as well as the many key knowledge gaps that remain.